208 related articles for article (PubMed ID: 25170952)
1. Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery.
Shirazi AN; Paquin KL; Howlett NG; Mandal D; Parang K
Molecules; 2014 Aug; 19(9):13319-31. PubMed ID: 25170952
[TBL] [Abstract][Full Text] [Related]
2. Cyclic peptide-capped gold nanoparticles as drug delivery systems.
Nasrolahi Shirazi A; Mandal D; Tiwari RK; Guo L; Lu W; Parang K
Mol Pharm; 2013 Feb; 10(2):500-11. PubMed ID: 22998473
[TBL] [Abstract][Full Text] [Related]
3. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters.
Nasrolahi Shirazi A; Tiwari RK; Oh D; Sullivan B; McCaffrey K; Mandal D; Parang K
Mol Pharm; 2013 Aug; 10(8):3137-51. PubMed ID: 23834324
[TBL] [Abstract][Full Text] [Related]
4. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
5. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
6. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
[TBL] [Abstract][Full Text] [Related]
7. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
8. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte.
Guo S; Huang Y; Jiang Q; Sun Y; Deng L; Liang Z; Du Q; Xing J; Zhao Y; Wang PC; Dong A; Liang XJ
ACS Nano; 2010 Sep; 4(9):5505-11. PubMed ID: 20707386
[TBL] [Abstract][Full Text] [Related]
9. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
Rahme K; Guo J; Holmes JD; O'Driscoll CM
Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
[TBL] [Abstract][Full Text] [Related]
11. Non-Covalent Associates of siRNAs and AuNPs Enveloped with Lipid Layer and Doped with Amphiphilic Peptide for Efficient siRNA Delivery.
Poletaeva J; Dovydenko I; Epanchintseva A; Korchagina K; Pyshnyi D; Apartsin E; Ryabchikova E; Pyshnaya I
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029512
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol.
Niikura K; Kobayashi K; Takeuchi C; Fujitani N; Takahara S; Ninomiya T; Hagiwara K; Mitomo H; Ito Y; Osada Y; Ijiro K
ACS Appl Mater Interfaces; 2014 Dec; 6(24):22146-54. PubMed ID: 25466488
[TBL] [Abstract][Full Text] [Related]
13. Immobilization of HIV-1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery.
Ahwazi RP; Kiani M; Dinarvand M; Assali A; Tekie FSM; Dinarvand R; Atyabi F
J Cell Physiol; 2020 Mar; 235(3):2049-2059. PubMed ID: 31364167
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic Cell-Penetrating Peptides Containing Natural and Unnatural Amino Acids as Drug Delivery Agents.
Salehi D; Mozaffari S; Zoghebi K; Lohan S; Mandal D; Tiwari RK; Parang K
Cells; 2022 Mar; 11(7):. PubMed ID: 35406720
[TBL] [Abstract][Full Text] [Related]
15. Insights into cell penetrating peptide conjugated gold nanoparticles for internalization into bacterial cells.
Kumar M; Tegge W; Wangoo N; Jain R; Sharma RK
Biophys Chem; 2018 Jun; 237():38-46. PubMed ID: 29656216
[TBL] [Abstract][Full Text] [Related]
16. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
17. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
18. Surface engineering of gold nanoparticles for in vitro siRNA delivery.
Zhao E; Zhao Z; Wang J; Yang C; Chen C; Gao L; Feng Q; Hou W; Gao M; Zhang Q
Nanoscale; 2012 Aug; 4(16):5102-9. PubMed ID: 22782309
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and study of cell-penetrating peptide-modified gold nanoparticles.
Boussoufi F; Gallón SMN; Chang R; Webster TJ
Int J Nanomedicine; 2018; 13():6199-6205. PubMed ID: 30349244
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
